1. Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection;Chang;Eur. J. Pharm. Biopharm.,2017
2. Chang, R.Y.K., Chen, K., Wang, J., Wallin, M., Britton, W., Morales, S., Kutter, E., Li, J., Chan, H.-K., 2017b. Anti-Pseudomonal activity of phage PEV20 in a dry powder formulation—A proof-of-principle study in a murine lung infection model. Antimicrob. Agents Chemother., AAC. 01714-01717.
3. Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization;Chang;Bioeng. & Transl. Med.,2020
4. Storage stability of inhalable phage powders containing lactose at ambient conditions;Chang;Int. J. Pharm.,2019
5. Phage therapy for respiratory infections;Chang;Adv. Drug Deliv. Rev.,2018